Osteoporosis
From the Journals
Any bone break increases risk for subsequent fracture in older women
Although most guidelines warn of subsequent fracture risk after hip and spine fractures, the increased risk is seen in a multitude of other bone...
Guidelines
Don’t screen for vitamin D in general population, says USPSTF
There is insufficient evidence that screening for vitamin D deficiency among the asymptomatic general population is of any benefit, concludes an...
Conference Coverage
Denosumab now dominant therapy for osteoporosis linked to cancer
In changing patterns of osteoporosis drug prescriptions, denosumab has risen to the top of cancer indications.
From the Journals
Abdominal aortic calcification may further raise known fracture risk
Men with a prevalent vertebral fracture on lateral spine radiograph had even greater risk for future osteoporotic fractures with increasing...
Guidelines
Don’t discontinue osteoporosis meds for COVID-19 vaccines, expert guidance says
Recommendations help physicians distinguish between a reaction to the vaccine and a reaction to medication.
From the Journals
Bone loss common in kidney stone patients, yet rarely detected
Almost one-quarter of patients diagnosed with kidney stones have osteoporosis or a fracture history on diagnosis, yet few undergo bone mineral...
Conference Coverage
Vitamin D deficiency linked to early cognitive impairment in MS
This association might represent a marker of future disability, supporting the need for prompt supplementation.
From the Journals
Metformin for pediatric obesity? Researchers review the evidence
Prescribing medications off label for the treatment of obesity in children and adolescents may not be ideal, but it could be reasonable in certain...
Conference Coverage
Romosozumab may not increase cardiovascular risk after all
Could a cardioprotective effect of bisphosphonates in a pivotal clinical trial of romosozumab explain why the biologic was given a black-box...
From the Journals
Cumulative exposure to high-potency topical steroid doses drives osteoporosis fractures
"A 3% increase in the relative risk of osteoporosis and MOF was observed per doubling of the TCS dose."
From the Journals
Could an osteoporosis drug reduce need for hip revision surgery?
Denosumab, widely used to treat osteoporosis, may reduce the need for revision surgery due to aseptic loosening of the prosthesis in patients with...